Skip to search formSkip to main contentSkip to account menu

NCI/ADR-RES

An adriamycin-resistant cell line established by Batist, et al., in 1986, intended to be derived from the breast cancer cell line MCF-7. Recent… 
National Institutes of Health

Search for papers about NCI/ADR-RES

Search papers